This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2009 Jul;15(7):777-8.

doi: 10.1177/1352458509106713.

Standards for sample composition and impairment classification in neuropsychological studies of multiple sclerosis

PMID: 19542261
DOI: 10.1177/1352458509106713

Editorial

Standards for sample composition and impairment classification in neuropsychological studies of multiple sclerosis

Rhb Benedict. Mult Scler. 2009 Jul.

. 2009 Jul;15(7):777-8.

doi: 10.1177/1352458509106713.

Author

PMID: 19542261
DOI: 10.1177/1352458509106713

No abstract available

PubMed Disclaimer

Comment on

Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
Patti F, Amato MP, Trojano M, Bastianello S, Tola MR, Goretti B, Caniatti L, Di Monte E, Ferrazza P, Brescia Morra V, Lo Fermo S, Picconi O, Luccichenti G; COGIMUS Study Group. Patti F, et al. Mult Scler. 2009 Jul;15(7):779-88. doi: 10.1177/1352458509105544. Mult Scler. 2009. PMID: 19542262

Similar articles

Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
Patti F, Amato MP, Trojano M, Bastianello S, Tola MR, Goretti B, Caniatti L, Di Monte E, Ferrazza P, Brescia Morra V, Lo Fermo S, Picconi O, Luccichenti G; COGIMUS Study Group. Patti F, et al. Mult Scler. 2009 Jul;15(7):779-88. doi: 10.1177/1352458509105544. Mult Scler. 2009. PMID: 19542262
Assessing disability progression with the Multiple Sclerosis Functional Composite.
Rudick RA, Polman CH, Cohen JA, Walton MK, Miller AE, Confavreux C, Lublin FD, Hutchinson M, O'Connor PW, Schwid SR, Balcer LJ, Lynn F, Panzara MA, Sandrock AW. Rudick RA, et al. Mult Scler. 2009 Aug;15(8):984-97. doi: 10.1177/1352458509106212. Mult Scler. 2009. PMID: 19667023
Disability progression in a clinical trial of relapsing-remitting multiple sclerosis: eight-year follow-up.
Rudick RA, Lee JC, Cutter GR, Miller DM, Bourdette D, Weinstock-Guttman B, Hyde R, Zhang H, You X. Rudick RA, et al. Arch Neurol. 2010 Nov;67(11):1329-35. doi: 10.1001/archneurol.2010.150. Epub 2010 Jul 12. Arch Neurol. 2010. PMID: 20625068 Clinical Trial.
Benefits of glatiramer acetate in the treatment of relapsing-remitting multiple sclerosis.
Johnson KP, Due DL. Johnson KP, et al. Expert Rev Pharmacoecon Outcomes Res. 2009 Jun;9(3):205-14. doi: 10.1586/erp.09.20. Expert Rev Pharmacoecon Outcomes Res. 2009. PMID: 19527092 Review.
Early interferon beta treatment in multiple sclerosis: nursing care implications of the BENEFIT study.
Webb UH. Webb UH. J Neurosci Nurs. 2008 Dec;40(6):356-61. J Neurosci Nurs. 2008. PMID: 19170303 Review.

See all similar articles

Cited by

Isolated cognitive impairment in people with multiple sclerosis: frequency, MRI patterns and its development over time.
Bouman PM, van Dam MA, Jonkman LE, Steenwijk MD, Schoonheim MM, Geurts JJG, Hulst HE. Bouman PM, et al. J Neurol. 2024 May;271(5):2159-2168. doi: 10.1007/s00415-024-12185-8. Epub 2024 Jan 30. J Neurol. 2024. PMID: 38286843 Free PMC article.
Cognitive performance in multiple sclerosis: what is the role of the gamma-aminobutyric acid system?
Huiskamp M, Yaqub M, van Lingen MR, Pouwels PJW, de Ruiter LRJ, Killestein J, Schwarte LA, Golla SSV, van Berckel BNM, Boellaard R, Geurts JJG, Hulst HE. Huiskamp M, et al. Brain Commun. 2023 May 3;5(3):fcad140. doi: 10.1093/braincomms/fcad140. eCollection 2023. Brain Commun. 2023. PMID: 37180993 Free PMC article.
Looking anew at cognitive dysfunction in multiple sclerosis: the gorilla in the room.
Feinstein A, Lapshin H, O'Connor P. Feinstein A, et al. Neurology. 2012 Sep 11;79(11):1124-9. doi: 10.1212/WNL.0b013e3182698da3. Epub 2012 Aug 29. Neurology. 2012. PMID: 22933746 Free PMC article.
Episodic Past, Future, and counterfactual thinking in Relapsing-Remitting Multiple sclerosis.
Ayala OD, Banta D, Hovhannisyan M, Duarte L, Lozano A, García JR, Montañés P, Davis SW, De Brigard F. Ayala OD, et al. Neuroimage Clin. 2022;34:103033. doi: 10.1016/j.nicl.2022.103033. Epub 2022 May 5. Neuroimage Clin. 2022. PMID: 35561552 Free PMC article.
APOE epsilon4 and the cognitive genetics of multiple sclerosis.
Ghaffar O, Reis M, Pennell N, O'Connor P, Feinstein A. Ghaffar O, et al. Neurology. 2010 May 18;74(20):1611-8. doi: 10.1212/WNL.0b013e3181e074a7. Neurology. 2010. PMID: 20479360 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon